C-QUALITY: Cost and Quality-of-Life Pharmacoeconomic Analysis of Antidepressants in Major Depressive Disorder in Italy.

CONCLUSION: The results indicate that escitalopram is the most cost-effective pharmacological treatment strategy for the Italian health service compared with other SSRIs and all SNRIs used in the first-line treatment of MDD. PMID: 23929174 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23929174?dopt=Abstract

Source: Advances in Therapy - August 9, 2013 Category: Drugs & Pharmacology Authors: Mencacci C, Aguglia E, Biggio G, Cappellari L, Di Sciascio G, Fagiolini A, Maina G, Tortorella A, Katz P, Ripellino C Tags: Adv Ther Source Type: research